Xylem (XYL) Tops Q1 EPS by 10c, Revenues Beat; Raises FY21 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/5/2026
- Dow claims record closing high, S&P 500 advances; chip selloff weighs on Nasdaq
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- HSBC stays aggressive on stocks, asks what could turn it bearish
- SpaceX sets IPO price at $135 ahead of roadshow in break with Wall Street norms
- Crypto stocks sink as Bitcoin hits a 4-month low
- Wells Fargo Upgrades Oscar Health Inc (OSCR) to Equal Weight 'on Greater Confidence in Exchange Market Trajectory in 2026'
- LCI Industries names interim CEO as Jason Lippert retires
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- Dow claims record closing high, S&P 500 advances; chip selloff weighs on Nasdaq
- Morgan Stanley lifts MU and SNDK targets, sees 2-3 years of tight memory supply
Xylem Reports First Quarter 2021 Results
May 4, 2021 6:55 AM EDTRevenue growth 12% on a reported basis, 8% organically Double-digit orders growth across all business segments, reflecting strong commercial momentum and underlying demand in critical infrastructure Adjusted EBITDA margin of 17.1%, up 480 basis points; net income as a percentage of revenue was 6.9%, up 350 basis points Reported net income of $87 million or $0.48 per share; adjusted net income of $102 million or $0.56 per share Raising full-year organic revenue guidance to a range of 5% to 7%, and adjusted earnings per share to a range of $2.50 to $2.70
RYE BROOK,... More
